• Wang, X., Shinjo, K., Kumegawa, K., Maruyama, R., Mii, S., Shiraki, Y., Nishimura, T., Murofushi, Y., Suzuki, M., Kabasawa, T., Futakuchi, M., Kanai, A., Suzuki, Y., Enomoto, A. and Kondo, Y.
  Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer.
  Br. J. Cancer, in press (2025)
• Toyohara, Y., Sone, K., Kumegawa, K., Yamamoto, Y., Hachijo, R., Kukita, A., Taguchi, A., Ikemura, M., Miyamoto, Y., Tanikawa, M., Iriyama, T., Mori, M., Hamamoto, R., Ushiku, T., Oda, K., Hirota, Y., Maruyama, R. and Osuga, Y.
  Synthetic lethality from the combination of a histone methyltransferase SUV39H2 inhibitor and a poly (ADP-ribose) polymerase inhibitor for uterine leiomyosarcoma.
  BMC Cancer, 25, 1873 (2025)
• Sasaki, N., Homme, M. and Kitajima, S.
  Mapping the inflammatory origins of lung cancer.
  Cancer Cell,  in press (2025)
• Tenma, T., Yoshida, R., Yanada, H., Nitanai, K., Nagato, T., Oyama, K., Sasaki, N., Homme, M., Mori, C., Ohkuri, T., Ono, Y., Tange, S., Minami, Y., Kobayashi, H., Mizukami, Y., Barbie, D. A., Kitajima, S. and Sasaki, T.
  Dipeptidyl peptidase 4 restoration facilitates anti-tumor immunity in KRAS-LKB1-mutant lung cancer.
  Cancer Res. Commun., in press (2025)
• Yoshido, A., Ishiguro, K., Kitajima, H., Niinuma, T., Kumegawa, K., Maezawa, M., Tsukahara, T., Toyota, M., Yorozu, A., Sasaki, H., Yamamoto, E., Kai, M., Idogawa, M., Torigoe, T., Nakase, H., Maruyama, R. and Suzuki, H.
  DOT1L inhibition exerts the anti-tumor effect by activating interferon signaling in breast cancer cells.
  Clin. Epigenetics, 17, 201 (2025)

more